Y-Intercept (HK)’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.36M | Buy |
74,891
+38,809
| +108% | +$707K | 0.03% | 786 |
|
2025
Q1 | $716K | Buy |
36,082
+6,333
| +21% | +$126K | 0.05% | 544 |
|
2024
Q4 | $510K | Buy |
+29,749
| New | +$510K | 0.03% | 714 |
|
2024
Q3 | – | Sell |
-34,055
| Closed | -$381K | – | 1249 |
|
2024
Q2 | $381K | Buy |
+34,055
| New | +$381K | 0.02% | 935 |
|
2023
Q3 | – | Sell |
-19,204
| Closed | -$70.9K | – | 1008 |
|
2023
Q2 | $70.9K | Buy |
+19,204
| New | +$70.9K | 0.01% | 1164 |
|
2022
Q2 | – | Sell |
-48,328
| Closed | -$88K | – | 831 |
|
2022
Q1 | $88K | Buy |
+48,328
| New | +$88K | 0.02% | 680 |
|
2021
Q3 | – | Sell |
-16,656
| Closed | -$27K | – | 620 |
|
2021
Q2 | $27K | Buy |
+16,656
| New | +$27K | 0.01% | 576 |
|